Your browser is currently set to block cookies. Not all features of our website will work as intended. Please turn on cookies or check if you have another program set to block cookies to allow full website functionality.
You're currently using an unsupported browser. Not all features of this website will work as intended. Please try again with a different browser.
In the past few years, it seems many patients deferred procedures as a result of economic hardship. Improving macroeconomic conditions should drive patient utilization rates higher.
Looming patent expirations, legislative uncertainty and disappointing R&D results have long weighed on Pharmaceuticals stocks. But while those fears help explain the past, focusing on them exclusively can blind your view of the future.
